Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/31/2026

1. PCG
2. NVDA
3. AVGO
4. CNS
5. ALNY
6. SRE
7. ATTO
8. BRVE
9. EIX
10. EC

Go back to Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Kiniksa Pharmaceuticals, Ltd. (KNSA) Tops Q2 EPS by 14c

August 3, 2022 7:34 AM EDT

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) reported Q2 EPS of ($0.29), $0.14 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $26.97 million versus the consensus estimate of $28.42 million.

GUIDANCE:

Kiniksa Pharmaceuticals, Ltd. sees FY2022 ARCALYST revenue of $115-130... More